Where can I buy Infigratinib?
Infigratinib/Infigratinib (Infigratinib) is a targeted therapy used to treat certain types of cancer. It belongs to a class of drugs called "Multikinase inhibitors", which are mainly used to treat cholangiocarcinoma (Cholangiocarcinoma).
Infigratinib/Infigratinib It is not currently available in the country, and it is unlikely to be included in medical insurance. Patients cannot purchase it domestically and can only purchase it through overseas channels. Foreign Infigratinib/Infigratinib only has original drugs, only American original drugs, and the price is as high as about 200,000.
Cholangiocarcinoma is a relatively rare but dangerous malignant tumor that originates in the biliary system, including the intrahepatic, extrahepatic, and papillary portions of the bile ducts. This cancer is generally divided into three main types: intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and papillary cholangiocarcinoma. Each of these cancer types can have different pathological characteristics and treatment challenges.

The pharmacological mechanism of Infitinib/Infigratinib involves inhibiting the activity of specific growth factor receptors, mainly fibroblast growth factor receptors (Fibroblast Growth Factor Receptor, FGFR). FGFR is a type of cell surface receptor that plays a key role in cell growth and differentiation. In some patients with cholangiocarcinoma, there are abnormalities in the FGFR gene that cause these receptors to be overactive, promoting abnormal growth and spread of cancer cells. Infigratinib/Infigratinib inhibits the activity of FGFR, which can interfere with these abnormal signaling pathways, thereby slowing down the growth and spread of cancer cells.
Infigratinib/InfigratinibTreatment may be used when the clinician, after evaluating the patient's condition, deems it an appropriate treatment option. Treatment usually involves oral medication, which patients need to take as often as recommended by their doctor. During treatment, patients typically undergo regular medical monitoring and evaluation to ensure the efficacy and tolerability of the medication and to manage any possible side effects or complications.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)